FDA says single-dose shot from J&J prevents severe COVID
Study shows opioid use among US patients with knee osteoarthritis costs 14 billion dollars in societal costs
25 February 2021Staff wellbeing: NHS England expands support with 40 hubs
25 February 2021FDA says single-dose shot from J&J prevents severe COVID
Johnson & Johnson’s single-dose vaccine offers strong protection against severe COVID-19, according to an analysis released Wednesday by U.S. regulators that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic.
